Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|9|1|28-47

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.9, Iss.1, 2015-04, pp. : 28-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor

By  

Drug Metabolism Letters, Vol. 6, Iss. 1, 2012-01 ,pp. : 33-42

Bentham Science Publishers

Access to resources Recommend Favorite

Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species

By  

Drug Metabolism Letters, Vol. 1, Iss. 2, 2007-04 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

A novel orally active inhibitor of HLE

By Varga M.   Kapui Z.   Batori S.   Nagy L.T.   Vasvari-Debreczy L.   Mikus E.   Urban-Szabo K.   Aranyi P.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 421-425

Elsevier

Access to resources Recommend Favorite

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

By Kumar Gondi N.   Jayanti Venkata K.   Johnson Marianne K.   Uchic John   Thomas Samuel   Lee Ronald D.   Grabowski Brian A.   Sham Hing L.   Kempf Dale J.   Denissen Jon F.   Marsh Kennan C.   Sun Eugene   Roberts Stanley A.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1622-1630

Springer Publishing Company

Access to resources Recommend Favorite

Gender Effects on Rat Metabolism of AMG 900, an Orally Available Small Molecule Aurora Kinase Inhibitor

By  

Drug Metabolism Letters, Vol. 5, Iss. 4, 2011-12 ,pp. : 290-297

Bentham Science Publishers

Access to resources Recommend Favorite